Your browser doesn't support javascript.
loading
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders.
Harrington, Patrick; Kurshan, Ashwini; Delord, Marc; Lechmere, Thomas; Sheikh, Amna; Saunders, Jamie; Saha, Chandan; Dillon, Richard; Woodley, Claire; Asirvatham, Susan; Curto-Garcia, Natalia; Sullivan, Jennifer O'; Kordasti, Shahram; Radia, Deepti; McLornan, Donal; Malim, Michael H; Harrison, Claire; Doores, Katie J; de Lavallade, Hugues.
Afiliación
  • Harrington P; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Kurshan A; School of Cancer and Pharmaceutical Science, King's College London, London, United Kingdom.
  • Delord M; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
  • Lechmere T; Department of Population Health Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
  • Sheikh A; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
  • Saunders J; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Saha C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Dillon R; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Woodley C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Asirvatham S; Department of Medicine and Molecular Genetics, King's College London, London, United Kingdom.
  • Curto-Garcia N; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Sullivan JO; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Kordasti S; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Radia D; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • McLornan D; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Malim MH; School of Cancer and Pharmaceutical Science, King's College London, London, United Kingdom.
  • Harrison C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Doores KJ; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • de Lavallade H; Department of Clinical Haematology, University College Hospital, London, United Kingdom.
Blood Adv ; 7(10): 1954-1957, 2023 05 23.
Article en En | MEDLINE | ID: mdl-36083126
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos